Carolyn C. Tang Arcus Biosciences, Inc. (RCUS) insider trading activity

Carolyn C. Tang is General Counsel of Arcus Biosciences, Inc.. Currently has a direct ownership of 124,734 shares of RCUS, which is worth approximately $2.5 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 6,810 shares (Common Stock) at a price of $22.16 per share, resulting in proceeds of $150,909. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K

9.37% 3M change

23.96% 12M change

Total Value Held $2.5 Million

Carolyn C. Tang Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2025	SELL Open market or private sale	$150,909 $22.16 p/Share	6,810 Reduced 5.18%	124,734 Common Stock
Dec 16 2025	SELL Open market or private sale	$167,557 $21.88 p/Share	7,658 Reduced 5.5%	131,544 Common Stock
Jan 23 2025	BUY Grant, award, or other acquisition	-	37,000 Added 21.19%	137,623 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$182,331 $16.08 p/Share	11,339 Reduced 10.13%	100,623 Common Stock
Jun 15 2024	SELL Payment of exercise price or tax liability	$70,968 $16.97 p/Share	4,182 Reduced 3.62%	111,364 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	26,700 Added 18.9%	114,579 Common Stock
Dec 19 2023	SELL Sale (or disposition) back to the issuer	$73,734 $18.09 p/Share	4,076 Reduced 4.43%	87,879 Common Stock

Dec 18 2023	SELL Sale (or disposition) back to the issuer	$70,800 $17.74 p/Share	3,991 Reduced 4.16%	91,955 Common Stock
Jun 16 2023	SELL Sale (or disposition) back to the issuer	$55,960 $19.35 p/Share	2,892 Reduced 2.93%	95,902 Common Stock
Jan 23 2023	BUY Grant, award, or other acquisition	-	34,000 Added 25.85%	97,539 Common Stock
Dec 16 2022	SELL Open market or private sale	$78,086 $30.95 p/Share	2,523 Reduced 8.11%	28,584 Common Stock
Jun 17 2022	SELL Open market or private sale	$33,484 $22.0 p/Share	1,522 Reduced 5.98%	23,909 Common Stock
Jun 16 2022	SELL Open market or private sale	$29,008 $20.72 p/Share	1,400 Reduced 5.22%	25,431 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	16,250 Added 32.46%	33,814 Common Stock
Dec 17 2021	SELL Open market or private sale	$24,948 $40.11 p/Share	622 Reduced 3.42%	17,564 Common Stock
Dec 16 2021	SELL Open market or private sale	$19,495 $40.03 p/Share	487 Reduced 2.61%	18,186 Common Stock
Jun 17 2021	SELL Open market or private sale	$38,030 $23.68 p/Share	1,606 Reduced 9.46%	15,362 Common Stock
Jun 16 2021	SELL Open market or private sale	$32,005 $24.45 p/Share	1,309 Reduced 7.16%	16,968 Common Stock
Jan 19 2021	BUY Grant, award, or other acquisition	-	12,538 Added 38.67%	19,886 Common Stock

CCT

Carolyn C. Tang

General Counsel

Hayward, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Value

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcus Biosciences, Inc.

Track Activities on RCUS

Account